Catalog Download Brands Marketing Channels Business Cooperation Contact Us Site Map
中文版
CCPG
Prescription Drugs
Hematology/Oncology
Musculo-skeletal system
Product Finder
Search

Company Name
Search


Keyword
Search
Imatinib mesylate 100mg Home > Prescription Drugs >Hematology/Oncology> Hematology/Oncology
 
Product No.
C500014
Class No .
E221
Name
Leevk
Ingredients
Imatinib mesylate
Dosage Form
F.C.Tab.
Dose
100mg
Indications
Leevk has approved as first-line treatment for Philadelphia chromosome (Ph)-positive CML.
Leevk was approved for use after the surgical removal of KIT-positive tumors to help prevent recurrence and also in unresectable KIT-positive GISTs.
Dosage and Administration
Chronic myelogenous leukemia: 400mg/daily
Accelerated phase and blast crisis: 600mg/daily.
Unresection and post-section of GIST patient: 400mg/daily
Package
10T/PTP, 12PTP/Box
Drug Type
Prescription Drugs
Controlled Drug
No
Area of Production
Taiwan
Health Insurance No.
AC57915100
Health Insurance Price
$598
CYH
Relatived Products
Pemetrexed 500mg
Pemetrexed 100mg
GEFITINIB 250mg